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Epidemiology of obesity 
Increased accumulation of fat tissue leads to 
obesity. The most common ways to evaluate 
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obesity are by the calculation of the body mass 
index (BMI), the measurement of waist 
circumference (WC) and the calculation of the 
ratio of the circumference of waist and hip 
Abstract 
Obesity results from a complex interaction of genetic, hormonal, physiological, anatomical, psychological, 
behavioral and environmental factors causing an imbalance between energy intake and energy expenditure. 
According to the World Health Organization, the estimated number of obese people around the world has 
doubled from 1980, meaning that more than 600 million people worldwide are obese. 
Obesity is associated with low-level chronic inflammation and represents a major risk factor for cardiovascular 
and metabolic diseases, but also some cancers. Centers that regulate food intake and energy balance are 
placed in the hypothalamus. Chemical signals are transmitted between hypothalamic neurons, and those 
neurons also affect the secretion of different hormones that are important for maintaining energy balance and 
metabolism. Moreover, genetic predisposition is also a risk factor for obesity development. Key neuronal 
populations for maintaining energy balance are the orexigenic agouti related peptide (AgRP)/neuropeptide Y 
(NPY) neurons and the anorexigenic proopiomelanocortin (POMC) neurons. This review attempts to present the 
prevalence and the major pathways regulating energy balance that may be affected by many environmental 
and social factors, such as emotions and human behavior, and can lead to obesity. 
(Jukić I, Kibel A, Kibel D, Drenjančević, I. Intrinsic Control and Environmental Factors in Food Consumption 
Related to Obesity. SEEMEDJ 2017;1(1);121-129) 
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(WHR). A BMI of 20-25 kg/m2 is considered 
normal; 25-30 kg/m2 is overweight; 30-40 
kg/m2 is defined as obesity and >40 kg/m2 is 
defined as extreme obesity. For children and 
adolescents, a BMI >95 percentile is considered 
overweight/obesity (1). A waist circumference 
(WC) of at least 88 cm for women and 102 cm for 
men is defined as obesity (2).  A WHR above 1.0 
in male subjects and above 0.6 in women is 
considered as an obesity pattern (3). The 
prevalence of obesity in the general population 
is increasing worldwide. Based on the Nutrition 
Examination Survey (NHANES) 1999–2000 in the 
USA, the prevalence of overweight in adults was 
64.5% and the prevalence of obesity was 30.5% 
(4). The most comprehensive overview of the 
prevalence of obesity is provided by the World 
Health Organization (WHO) Global Status Report 
on noncommunicable diseases 2014 (5), which 
showed that the age-standardized prevalence 
of obesity in adults aged 18 years and over (cut-
off point set to BMI ≥30 kg/m2) in the USA was 
33.7%. Canada had a prevalence of obesity of 
28%, Mexico 28.1%, Argentina 26.3% and Brazil 
20%. The same publication reported that in 
Europe, the prevalence of obesity among the 
general population is as follows:  UK 28.1%, 
Slovenia 25.1%, Spain 23.7%, Croatia 23.3%, Italy 
21%, Germany 20.1% Turkey 29.5, France 23.9% 
and Bosnia and Herzegovina 17.9%. Interestingly, 
in Asia the prevalence of obesity was 
significantly lower: the prevalence of obesity 
was in China 6.9%, India 4.9% and Japan 3.3%. 
Australia has a prevalence of obesity in the 
general population of 28.6%. In Africa, there is a 
wide range of obesity prevalence, from 28.9% in 
Egypt to 10.5% in Zimbabwe, 11% in Congo and 
11.4% in Cameroon (5). Based on WHO data, in 
2014 more than 1.9 billion adults aged 18 years 
and older (39% [38% of men and 40% of women]) 
were overweight. Of these over 600 million 
adults were obese—about 13% of the world’s 
adult population (11% of men and 15% of women). 
The worldwide prevalence of obesity more than 
doubled between 1980 and 2014 (5).  
The prevalence of obesity is linked to the 
prevalence of various cardiometabolic diseases, 
such as diabetes mellitus. Recently, in 44 
observational or clinical studies that were 
evaluated in a systematic literature review by 
Colosia et al, the obesity prevalence in T2DM 
subjects  was determined based on BMI or WC 
(2). Based on BMI, the prevalence of obesity in 
that population group was 30-85.5% in Asia, 32.7-
64.1% in Europe, 26.8-64.3% in North America, 
32.5-59% in South America and 32-42.5% in Africa. 
The prevalence of obesity in T2DM patients 
based on waist circumference was 56-67% in 
Europe, 54.6% in Africa and 20-81% in Asia. 
However, there were no studies taking into 
account obesity based on WC in that 
publication, and not all countries were covered 
by the examined studies (2). Due to its effects on 
hormonal balance, autonomic system function 
and various organ functions, obesity represents 
a significant risk factor for many other chronic 
diseases such as hypertension, atherosclerosis, 
diabetes mellitus and chronic kidney disease.. 
The pathophysiological mechanism of 
obesity 
The development of obesity is a consequence of 
several pathophysiological factors. First of all, it 
is an imbalance of food intake and energy 
expenditure. The central control of energy 
balance by the hypothalamus and the feedback 
loop of peripheral metabolic factors from the 
gastrointestinal and endocrine system, including 
adipose tissue, are very important factors, 
particularly in obesity related to chronic stress 
and other cardiometabolic diseases. Genetic 
predisposition accounts for approximately 30% 
of the risk for obesity development (6). The most 
recognized mutations are those of receptors or 
hormones related to the regulation of feeding 
behavior, and subsequently energy balance: e.g. 
mutations of the leptin gene and the leptin 
receptor gene, the mutation of the 
proopiomelanocortin gene (POMC) and 
mutations of genes for melanocortin receptors 
(e.g. MCR-4) (7). These conditions lead to 
pathological obesity with other metabolic and 
hormonal imbalances. 
Central control of dietary intake (energy balance) 
An individual’s energy intake and expenditure 
must be balanced over time to ensure adequate 
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body composition and function (8). The quantity 
of food intake is regulated on a short-term basis, 
which controls the intake of food at each meal, 
and long-term, which is mainly concerned with 
the maintenance of normal quantities of body 
energy stores (9). The main homeostatic system 
involved in the regulation of energy balance is 
located in the hypothalamus, and the nucleus 
arcuatus has a central role in these processes. It 
functions by integrating neural and nutrient 
signals with hormonal signals that arise in the 
small intestine, liver, pancreas, adipose tissue 
and brainstem (10). The total daily energy intake 
is a function of the size, frequency, and 
qualitative composition of meals, and the 
perception of hunger and the decision to initiate 
a meal are determined by complex interactions 
between genetic, social, learned, environmental, 
circadian, and humoral factors (11).  
Centers for the control of hunger and satiety are 
located in the hypothalamus, Stimulation of the 
lateral nuclei causes hyperphagia (their 
destruction has the opposite effect), while 
stimulation of the ventromedial nuclei causes 
satiety and aphagia (8). Other areas add to the 
complexity: Paraventricular nuclei destruction 
leads to excessive eating, dorsomedial nuclei 
destruction leads to depressed eating, and 
arcuate nuclei are centers where several 
hormonal signals from the adipose tissue and 
gastrointestinal tract are integrated to regulate 
food intake (9). In addition to these main 
structures of the homeostatic system, an 
important role is played by the brain’s reward 
system — located in proximity to the 
hypothalamus with its main nodes centered on 
the ventral striatum. It includes the nucleus 
accumbens, the ventral pallidum, and the 
ventral tegmental area (10). 
Evolutionary development led to the 
emergence of protective central mechanisms 
that are focused on the resistance of fat loss and 
on the maintenance of body weight, crucial 
features that helped enable the survival of the 
human species throughout time (12). 
Unfortunately, such a system predisposes 
humans to obesity in times of abundance, with 
all the known adverse effects. Obesity has 
become one of the leading medical challenges 
of the 21st century (11). “Hunger hormones,” like 
orexin and ghrelin, as well as high-calorie food, 
incite individuals to eat, while “satiety hormones” 
like leptin, insulin and other so called “brain-gut 
peptides,” suppress feeding behavior (12).  
Weight increase and obesity can result from 
long-term imbalance between the hunger and 
satiety signals (12). 
There exist two neuronal populations that are 
crucial in energy balance homeostasis and are 
located in the arcuate nucleus of the 
hypothalamus: the orexigenic agouti related 
peptide (AGRP)/neuropeptide Y (NPY) neurons 
and the anorexigenic proopimelanocortin 
(POMC) neurons (10). Activation of the POMC 
neurons decreases food intake and increases 
energy expenditure. On the other hand, 
activation of the NPY-AGRP neurons exerts 
opposite effects, increasing food intake and 
reducing energy expenditure, with both of these 
neuronal groups having significant interaction 
(8). These neuronal groups are the main targets 
of hormones that regulate appetite, including 
leptin, ghrelin, insulin, cholecystokinin and 
others. POMC neurons secrete the alpha-
melanocyte-stimulating hormone (MSH), which 
acts via several types of melanocortine 
receptors (MCR) and through them leads to a 
reduction in food intake and an increase in 
energy expenditure (9), as discussed below. 
AGRP are antagonists of MCR, increasing food 
intake. NPY increases appetite and is produced 
when energy reserves in the body are low (9). 
Chronic stress and obesity 
Stress is an incentive that occurs in response to 
certain experiences, representing the state of 
disrupted hemostasis. The organism reacts to 
stress via the central and peripheral segments of 
the autonomic nervous system and via the 
hypothalamic-pituitary-adrenal (HPA) pathway. 
Response to stress can be acute condition, and 
is necessary for the maintenance of 
homeostasis, or chronic stress, which is 
prolonged and may cause some disease states. 
Acutely, within a few hours, glucocorticoids act 
to inhibit the secretion of CRH and ACTH. That 
physiological effect is noticeably altered in 
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chronic stress, where the effect of 
glucocorticoids on the brain is excitatory (13-15). 
Many recent studies have shown that chronic 
stress may contribute to an increased risk for the 
development of obesity and other metabolic 
diseases. One of the elementary responses to 
stress is mediated by the activation of the para-
ventricular nucleus of the hypothalamus that 
secretes a corticotrophin-releasing hormone 
(CRH), which stimulates the secretion of 
adrenocorticotrophin (ACTH) from the anterior 
pituitary gland. ACTH binds to its MC2R 
receptors on the adrenal cortex and thus 
stimulates the secretion of cortisol (13-15). 
Cortisol causes the elevation of blood glucose 
and insulin concentration, whose long-term 
effect may cause insulin resistance and diabetes 
mellitus type 2. 
The long-term effect of chronic stress on the 
HPA axis leads to increased accumulation of 
visceral fat, but it also has been shown that 
obesity represents a state of chronic systemic 
low-grade inflammation that may cause an 
impaired function of the HPA axis.  In the state of 
chronic stress, glucose metabolism is disrupted. 
The increased secretion of ACTH and hence a 
high level of glucocorticoids, primarily cortisol, is 
associated with weight gain and the high 
production of proinflammatory hormones and 
adipokines by adipose tissue depots (15-17). 
The main central targets of insulin (and leptin) 
action are the POMC and AgRP neurons of the 
arcuate nucleus of the hypothalamus. Some 
studies suggest a major physiological 
importance of insulin receptors in the brain in the 
long-term modulation of energy balance, 
whereas the disturbance of the insulin receptor 
Figure 1. Chronic stress and central mechanisms of weight gain 
Due to constant activation of the HPA axis during chronic stress, there is a marked increase in secretion of POMC, ACTH and 
glucocorticoids, which leads to enhanced blood glucose levels and increased insulin secretion. Persistent elevated insulin levels 
decreases sensitivity or number of insulin receptor in the NPY/AgRP region and reduce inhibition of the orexigenic neurons that 
leads to obesity. 
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gene may cause increased body fat and high 
plasma levels of insulin and leptin (18). Chronic 
stress also increases the activation of the 
sympathetic nervous system, and thus 
contributes to impaired glucose tolerance and 
to an increased risk for developing of 
cardiovascular events (19). Thus, chronic stress 
that activates the HPA axis, as well as the 
sympathetic nervous system, may progressively 
contribute to the occurrence of obesity and 
metabolic syndrome (Figure 1). 
The role of MSH receptors 
It is well accepted that the central melanocortin 
signaling pathway has a critical role in the 
maintenance of energy balance, and it is known 
that peptides generated from POMC have a key 
role in controlling food intake and weight gain 
(20, 21). Melanocortin receptors present a distinct 
family of G-protein-coupled receptors; they are 
coupled to adenylate cyclase and exert their 
effects primarily by activating a cAMP-
dependent signaling pathway (20). Melanocortin 
receptors are differently distributed in various 
kinds of tissue and differ from each other in their 
affinity for binding various melanocortins and/or 
their antagonists, agouti signaling protein (ASP) 
and agouti-related protein (AgRP) (20).  
Prohormone convertase 1 (PC1) is expressed in 
pituitary corticotrophs and produces ACTH, 
while the expression of PC1 and prohormone 
convertase 2 (PC2) within the hypothalamus 
leads to the production of α-, β- and γ-MSH (7). 
The actions of ACTH and melanocortins are 
mediated by specific interactions with five 
melanocortin receptors (MC1R to MC5R), two of 
which, MC3R and MC4R, are predominantly 
expressed within the central nervous system, 
and in the context of human energy balance and 
body weight regulation, they— especially 
MC4R— have the most important role (7,22). 
MC1R is expressed in pigment-producing cells 
of the skin and hair, and when α-MSH binds to it 
the production of pigment melanin is stimulated. 
Also MC1R is expressed on cells of the immune 
system, wherefore α-MSH has anti-
inflammatory effects (7). MC2R is an ACTH 
receptor expressed in the adrenal cortex, while 
MC3R is expressed in the brain (mainly in the 
hypothalamus, cortex, thalamus and 
hippocampus), and over it γ-MSH plays a role in 
cardiovascular functions and sodium and 
energy homeostasis (7). The β-MSH peptide 
performs its action in weight regulation by 
binding to MC4R, helping to maintain energy 
balance (7), and in this context has the most 
important role. MC5Rs are expressed at low 
levels in numerous tissues, including the 
sebaceous gland, where it has a role in 
sebaceous secretion (7). 
It is thought that the anorectic effect of POMC 
neurons is mediated via α- and β- MSH. Human 
and animal studies have shown that a lack of 
MC4R leads to obesity, hyperphagia and insulin 
resistance (23, 24), and in obese persons β- MSH 
mutations rather than α-MSH (25). As mentioned 
above, melanocortin receptors are distinguished 
by their ability to bind ligand, and under normal 
physiological conditions, ASP doesn`t have a 
role in the regulation of food intake since it 
antagonizes MC1R, but when ASP is synthesized 
from dermal papilla cells in very high 
concentrations, it acts as an antagonist of MC4R 
(20). It is thought that AGRP binds to neural MC3R 
and MC4R, and in genetically obese mice AGRP 
is overexpressed, indicating that AGRP has a 
physiological role in feeding behavior (20). No 
effect was observed on MC1R and MC2R. MC4R 
is specific since it binds both antagonists, ASP 
and AGRP, while MC3R binds AGRP, and MC1R 
binds only ASP (20). 
Food availability – food quality 
(salt/sugar) 
As never before, the food-based dietary 
diversity strategy has been put into the focus of 
worldwide political attention and has social, 
cultural, economic and environmental benefits 
(26). Although it is well known that dietary habits 
and health effects depend on ethnicity, gender, 
region and city (27), there is a widespread 
intention to improve world population health 
and individual health through diet (28). In the 
past, the concept of food quality was quite 
different compared to the present day, where an 
important role is given to modern marketing and 
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sophisticated industrial production methods of 
processed food rich in added sugar and salt (29).  
In the everyday diet, the sugar content has 
tripled during the last 50 years, and there is 
critical concern about dietary fructose, which 
has various negative effects on body 
metabolism (30). It is even popular to compare 
its effects with those that result from alcohol 
intake. Both metabolic processes are 
predominantly based on glycolysis, generate 
reactive oxygen species and result in a similar 
disease range (31). 
Kitchen salt, sodium chloride, has a very 
important role in the food industry. The 
consumption of salt, even much more than is 
necessary for normal homeostatic process in the 
human organism, attenuates bitter taste and 
enhances taste in general. Bakery products, a 
widely available and popular food category for 
every age group, are considered to be a major 
hidden salt source. 
In general, even though the word “addiction” has 
a negative connotation, much research suggests 
that consuming salty, sweet and fatty foods, for 
example fast food meals,  can produce similar 
neurophysiological effects as in certain 
addictive drugs, leading to human obesity in the 
general population (32). That kind of processed 
food induces effects that are overwhelming to 
our brain-reward circuitry in a way natural food 
does not (30). Innovative solutions need to be 
implemented by the food industry to replace 
sodium with more acceptable substances 
without customer dissatisfaction (33). 
The World Health Organization has taken aim at 
a 30% reduction in global salt intake by 2025 (34). 
Croatia is an example of a country with an 
organized national program for the reduction of 
excessive salt intake, with the goal of helping to 
develop consciousness about the negative 
impacts of salt on hypertension (35). 
Social interactions as extrinsic factor 
(mirror neurons) 
When discussing the physiological mechanisms 
related to food intake, we cannot avoid 
discussing what food means to human beings in 
addition to being simply “body fuel”. How does 
one distinguish between food as an elementary 
human need and food as part of social and 
emotional interaction? The external influence on 
individual food consumption is very complex; it 
depends on a variety of factors, and therefore 
some studies were overlap in the search for 
proper answers (36). Human beings have a 
tendency to imitate the behavior of others 
including behavior related to food intake, a 
phenomenon that is known to exist in the animal 
world as well (37). Through many psychological 
studies, it has been argued that the act of 
perceiving another person’s behavior creates a 
tendency to behave similarly oneself, which is 
called the “chameleon effect” (perception-
behavior link) (38).  In recent history, this and 
many similar correlations were explained by the 
discovery of “mirror” neurons —a distinct and 
intriguing group of neurons whose activities 
have been located in many different cortical 
areas, but were most extensively investigated in 
the ventral premotor region F5. They can 
transform specific sensory information into a 
motor format. Moreover, we can say in a way that 
“motor” or “sensory” neurons have an impact on 
either execution or observation, and the “mirror” 
neurons have both (39). They have a huge role in 
learning during the first developmental periods 
of life (40). The described functions of mirror 
neurons can be used to explain the adoption of 
the first dietary habits from our parents and 
other close persons, because imitation is a 
fundamental method through which children 
learn from their parents, including choices of 
food and food quantity. According to that 
concept, obese children display an altered 
conscious perception of their own weight (41). In 
that sense, the mirror neurons may represent 
independent neurophysiological pathways to 
stimulate overeating and in that way increase 
calorie intake (37). Furthermore, the perceived 
trend which includes a lack of physical activity 
combined with high calorie meals leads to a high 
BMI, and together they have been referred to as 
the “big two” contributors to obesity (41,42). As 
well as having a negative effect (43), peer 
relationships can also have positive influences 
on developing everyday habits (44). For instance, 
peer group physical activity is the strongest 
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predictor for individual physical activity (40). It is 
not well explained, but stigmas also have a huge 
effect on food intake, whereas with some 
exceptions, negative characteristics are 
assigned to those people who consume large 
amounts of food (45). By applying a 
multidisciplinary approach and using 
sophisticated neuroimaging methods, more 
useful information could be obtained not merely 
about the relationship between mirror neurons 
and food intake habits, but also about human 
behavior in general. 
In conclusion, the pathophysiology of obesity 
includes the complicated interaction of the 
autonomic nervous system and hormonal 
system with the neuropeptide feedback loops 
from the gastrointestinal system to the 
hypothalamic centers that regulate energy 
homeostasis. Moreover, it is significantly 
affected by human behavior, emotions and food 
intake. Thus, obesity is a preventable risk factor 
for other cardiometabolic diseases. 
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